Yonkers KA - Search Results

1

Health and economic impact of the premenstrual syndrome.

Borenstein JE, Dean BB, Endicott J, Wong J, Brown C, Dickerson V, Yonkers KA. Borenstein JE, et al. Among authors: yonkers ka. J Reprod Med. 2003 Jul;48(7):515-24. J Reprod Med. 2003. PMID: 12953326

2

Using the daily record of severity of problems as a screening instrument for premenstrual syndrome.

Borenstein JE, Dean BB, Yonkers KA, Endicott J. Borenstein JE, et al. Among authors: yonkers ka. Obstet Gynecol. 2007 May;109(5):1068-75. doi: 10.1097/01.AOG.0000259920.73000.3b. Obstet Gynecol. 2007. PMID: 17470584 Clinical Trial.

3

Differences in symptom scores and health outcomes in premenstrual syndrome.

Borenstein JE, Dean BB, Leifke E, Korner P, Yonkers KA. Borenstein JE, et al. Among authors: yonkers ka. J Womens Health (Larchmt). 2007 Oct;16(8):1139-44. doi: 10.1089/jwh.2006.0230. J Womens Health (Larchmt). 2007. PMID: 17937566

4

Evaluating the criteria used for identification of PMS.

Dean BB, Borenstein JE, Knight K, Yonkers K. Dean BB, et al. J Womens Health (Larchmt). 2006 Jun;15(5):546-55. doi: 10.1089/jwh.2006.15.546. J Womens Health (Larchmt). 2006. PMID: 16796482

5

Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.

Pearlstein TB, Halbreich U, Batzar ED, Brown CS, Endicott J, Frank E, Freeman EW, Harrison WM, Haskett RF, Stout AL, Yonkers KA. Pearlstein TB, et al. Among authors: yonkers ka. J Clin Psychiatry. 2000 Feb;61(2):101-9. doi: 10.4088/jcp.v61n0205. J Clin Psychiatry. 2000. PMID: 10732657 Clinical Trial.

6

Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.

Yonkers KA, Halbreich U, Freeman E, Brown C, Endicott J, Frank E, Parry B, Pearlstein T, Severino S, Stout A, Stone A, Harrison W. Yonkers KA, et al. JAMA. 1997 Sep 24;278(12):983-8. JAMA. 1997. PMID: 9307345 Clinical Trial.

7

ISPMD consensus on the management of premenstrual disorders.

Nevatte T, O'Brien PM, Bäckström T, Brown C, Dennerstein L, Endicott J, Epperson CN, Eriksson E, Freeman EW, Halbreich U, Ismail K, Panay N, Pearlstein T, Rapkin A, Reid R, Rubinow D, Schmidt P, Steiner M, Studd J, Sundström-Poromaa I, Yonkers K; Consensus Group of the International Society for Premenstrual Disorders. Nevatte T, et al. Arch Womens Ment Health. 2013 Aug;16(4):279-91. doi: 10.1007/s00737-013-0346-y. Epub 2013 Apr 27. Arch Womens Ment Health. 2013. PMID: 23624686 Free PMC article.

8

Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.

Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A. Yonkers KA, et al. Obstet Gynecol. 2005 Sep;106(3):492-501. doi: 10.1097/01.AOG.0000175834.77215.2e. Obstet Gynecol. 2005. PMID: 16135578 Clinical Trial.

9

Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs.

Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C, Roberts DL, Yonkers K. Steiner M, et al. J Womens Health (Larchmt). 2006 Jan-Feb;15(1):57-69. doi: 10.1089/jwh.2006.15.57. J Womens Health (Larchmt). 2006. PMID: 16417420 Review.

10

Sertraline in the treatment of premenstrual dysphoric disorder.

Yonkers KA, Halbreich U, Freeman E, Brown C, Pearlstein T. Yonkers KA, et al. Psychopharmacol Bull. 1996;32(1):41-6. Psychopharmacol Bull. 1996. PMID: 8927673 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page